Lexaria Bioscience Corp. (NASDAQ: LEXX) Kicks Off First-Ever Study on DehydraTECH-CBD for the Potential Treatment of Diabetes
In November 2021, Lexaria laid out its plans for several new and ongoing R&D programs, among them hormone replacement, dementia,…